STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro

BMB Reports

Volumn 45, Issue 11, 2012, Pages 629-634

  Wang, Haixiao ^a,d   Wu, Kuangjie ^a   Sun, Yuan ^d   Li, Yandong ^b,c   Wu, Mingyu ^a   Qiao, Qian ^a   Wei, Yuanjiang ^a   Han, Ze Guang ^b,c   Cai, Bing ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^d THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Cell proliferation; Hepatocellular carcinoma; Stanniocalcin 2

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; GLYCOPROTEIN; MAPK1 PROTEIN, HUMAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SIGNAL PEPTIDE; STC2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL ADHESION; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; GENETICS; HUMAN; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84871416593     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.11.086     Document Type: Article

References (27)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E. and Forman, D. (2011) Global cancer statistics. CA Cancer J. Clin. 61, 69-90.
2. Sherman, M. (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin. Liver Dis. 25, 143-154.
3. Hwang, S., Moon, D. B. and Lee, S. G. (2010) Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl. Int. 23, 723-727.
4. Villanueva, A. and Llovet, J. M. (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology. 140, 1410-1426.
5. Livraghi, T., Makisalo, H. and Line, P. D. (2011) Treatment options in hepatocellular carcinoma today. Scand. J. Surg. 100, 22-29.
6. Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S. T., Luk, J. M., Wigler, M., Hannon, G. J., Mu, D., Lucito, R., Powers, S. and Lowe, S. W. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267.
7. Levine, A. J. and Puzio-Kuter, A. M. (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science. 330, 1340-1344.
8. Flik, G., Labedz, T., Neelissen, J. A., Hanssen, R. G., Wendelaar Bonga, S. E. and Pang, P. K. (1990) Rainbow trout corpuscles of Stannius: stanniocalcin synthesis in vitro. Am. J. Physiol. 258, R1157-1164.
9. Sterba, T., Wagner, G. F., Schroedter, I. C. and Friesen, H. G. (1993) In situ detection and distribution of stanniocalcin mRNA in the corpuscles of Stannius of sockeye salmon, Oncorhynchus nerka. Mol. Cell Endocrinol. 90, 179-185.
10. Honda, S., Kashiwagi, M., Ookata, K., Tojo, A. and Hirose, S. (1999) Regulation by 1alpha,25-dihydroxyvitamin D(3) of expression of stanniocalcin messages in the rat kidney and ovary. FEBS Lett. 459, 119-122.
11. Wagner, G. F., Jaworski, E. M. and Haddad, M. (1998) Stanniocalcin in the seawater salmon: structure, function, and regulation. Am. J. Physiol. 274, R1177-1185.
12. Ishibashi, K., Miyamoto, K., Taketani, Y., Morita, K., Takeda, E., Sasaki, S. and Imai, M. (1998) Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem. Biophys. Res. Commun. 250, 252-258.
13. Nguyen, A., Chang, A. C. and Reddel, R. R. (2009) Stanniocalcin- 1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling pathway during oxidative stress. Oncogene. 28, 1982-1992.
14. Lai, K. P., Law, A. Y., Yeung, H. Y., Lee, L. S., Wagner, G. F. and Wong, C. K. (2007) Induction of stanniocalcin-1 expression in apoptotic human nasopharyngeal cancer cells by p53. Biochem. Biophys. Res. Commun. 356, 968-975.
15. Moore, E. E., Kuestner, R. E., Conklin, D. C., Whitmore, T. E., Downey, W., Buddle, M. M., Adams, R. L., Bell, L. A., Thompson, D. L., Wolf, A., Chen, L., Stamm, M. R., Grant, F. J., Lok, S., Ren, H. and De Jongh, K. S. (1999) Stanniocalcin 2: characterization of the protein and its localization to human pancreatic alpha cells. Horm. Metab Res. 31, 406-414.
16. Tamura, K., Furihata, M., Chung, S. Y., Uemura, M., Yoshioka, H., Iiyama, T., Ashida, S., Nasu, Y., Fujioka, T., Shuin, T., Nakamura, Y. and Nakagawa, H. (2009) Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci. 100, 914-919.
17. Law, A. Y. and Wong, C. K. (2010) Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp. Cell Res. 316, 3425-3434.
18. Volland, S., Kugler, W., Schweigerer, L., Wilting, J. and Becker, J. (2009) Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int. J. Cancer. 125, 2049-2057.
19. Fazio, E. N., Dimattia, G. E., Chadi, S. A., Kernohan, K. D., Pin CL. (2011) Stanniocalcin 2 alters PERK signalling and reduces cellular injury during cerulein induced pancreatitis in mice. BMC Cell Biol. 12, 17.
20. Ito D, Walker, J. R., Thompson, C. S., Moroz, I., Lin, W., Veselits, M. L., Hakim, A. M., Fienberg, A. A., Thinakaran, G. (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol. Cell Biol. 24, 9456-9469.
21. Tarn, W. Y. and Lai, M. C. (2011) Translational control of cyclins. Cell Div. 6,5.
22. Meyer, H. A., Tölle, A., Jung, M., Fritzsche, F. R., Haendler, B., Kristiansen, I., Gaspert, A., Johannsen, M., Jung, K. and Kristiansen, G. (2009) Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Eur Urol. 55, 669-678.
23. Yokobori, T., Mimori, K., Ishii, H., Iwatsuki, M., Tanaka, F., Kamohara, Y., Ieta, K., Kita, Y., Doki, Y., Kuwano, H. and Mori, M. (2010) Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. Ann. Surg. Oncol. 17, 2601-2607.
24. Yamamura, J., Miyoshi, Y., Tamaki, Y., Taguchi, T., Iwao, K., Monden, M., Kato, K. and Noguchi, S. (2004) mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci. 95, 887-892.
25. Schmitz, K. J., Wohlschlaeger, J., Lang, H., Sotiropoulos, G. C., Malago, M., Steveling, K., Reis, H., Cicinnati, V. R., Schmid, K. W. and Baba, H. A. (2008) Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 48, 83-90.
26. Qin, L. X. and Tang, Z. Y. (2002) The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J. Gastroenterol. 8, 193-199.
27. Too, H. P. (2003) Real time PCR quantification of GFRalpha-2 alternatively spliced isoforms in murine brain and peripheral tissues. Brain Res. Mol. Brain Res. 114, 146-153.